SMMT
#823
Summit Therapeutics Inc. - Common Stock
15.3 0 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.33%
Monthly Change
+5.96%
6 month change
-13.17%
Year Change
-22.96%
Previous Close
15.2 5
Open
15.3 0
Low
15.3 0
High
15.3 0
Volume
153
Financials
- Market Capitalization 11.88 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-11.92
Price to sales ratio
-18.9 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 731 |  EXEL Exelixis, Inc. - Common Stock | 56.04 USD | -0.81% | -0.21% | +5.14% | +43.55% | 14.09 B USD | ||
| 809 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 531.00 USD | -1.06% | -0.74% | +10.63% | +25.35% | 12.24 B USD | ||
| 828 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 228.28 USD | -2.36% | -5.79% | -10.25% | +75.33% | 11.75 B USD | ||
| 843 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 59.20 USD | +0.14% | -0.74% | +5.56% | +1.02% | 11.44 B USD |
Frequently asked questions about Summit Therapeutics Inc. - Common Stock
What is the Summit Therapeutics Inc. - Common Stock stock price today?
The current price of Summit Therapeutics Inc. - Common Stock (SMMT) is 15.3. Over the past 24 hours, the stock has changed by +0.33%. Follow the SMMT chart for real-time price dynamics.
What is the stock ticker of Summit Therapeutics Inc. - Common Stock?
Summit Therapeutics Inc. - Common Stock trades under the ticker SMMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Summit Therapeutics Inc. - Common Stock stock going up?
SMMT has changed by -4.20% over the last week, +5.96% over the last month, and -22.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Summit Therapeutics Inc. - Common Stock net income for the last quarter?
Summit Therapeutics Inc. - Common Stock reported net income of -189.42 M for the last quarter. The previous quarter showed -219.17 M, which means net income changed by +13.57%.
How many employees does Summit Therapeutics Inc. - Common Stock have?
As of the latest available data, Summit Therapeutics Inc. - Common Stock has 265 employees. Workforce size can provide additional context about the company's scale and operations.
What is Summit Therapeutics Inc. - Common Stock EBITDA?
Summit Therapeutics Inc. - Common Stock EBITDA is -199.45 M, and its EBITDA margin is 321.69 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Summit Therapeutics Inc. - Common Stock stock?
You can buy Summit Therapeutics Inc. - Common Stock (SMMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Summit Therapeutics Inc. - Common Stock stock?
Investing in Summit Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SMMT chart and related analysis on metatrader.com as part of your research.